Concepedia
Statistics
Publications
8
Citations
628
H-Index
Active since
2010
Affiliations
Novo Nordisk (United States)(Current)
University of Cincinnati Medical Center
Indiana University Bloomington
Ludwig-Maximilians-Universität München
Deutsches Diabetes-Zentrum e.V.
Stephanie A. Mowery is an author at Novo Nordisk (United States) specializing in signal transduction, endocrinology, and life sciences.
Publications per year
2010–2025
The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling
Qian Zhang, Robert Augustin, Mostafa Bakhti et al. · Cell Metabolism · 2021 · 298 citations · Full text
Life Sciences, Endocrinology, Neuroscience +15
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
Patrick J. Knerr, Stephanie A. Mowery, Jonathan D. Douros et al. · Molecular Metabolism · 2022 · 134 citations · Full text
Life Sciences, Endocrinology, Pharmacology +17
ABC and SLC Transporter Expression and Pot Substrate Characterization across the Human CMEC/D3 Blood−Brain Barrier Cell Line
Stephen M. Carl, David Lindley, P. O. Couraud et al. · Molecular Pharmaceutics · 2010 · 98 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +13
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes
Hüsün Sheyma Kizilkaya, Kimmie V. Sørensen, Jakob Sture Madsen et al. · Nature Metabolism · 2024 · 42 citations · Full text
Medicine, Endocrinology, Pharmacology +17
A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice
Jonathan D. Douros, Aaron Novikoff, Barent DuBois et al. · Molecular Metabolism · 2025 · 16 citations · Full text
1–5 of 8